Clicky

MiMedx Group, Inc(MDXG)

Description: MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA


Keywords: Biopharmaceutical Life Sciences Health Sciences Immunology Wound Sterilization Transplantation Medicine Allotransplantation

Home Page: www.mimedx.com

MDXG Technical Analysis

1775 West Oak Commons Court, NE
Marietta, GA 30062
United States
Phone: 770 651 9100


Officers

Name Title
Mr. K. Todd Newton Interim CEO & Director
Mr. Peter Martin Carlson CPA Chief Financial Officer
Mr. William F. Hulse IV Gen. Counsel & Chief Admin. Officer
Dr. Rohit Kashyap Ph.D. Pres of Wound Care & Surgical
Dr. Robert Benjamin Stein M.D., Ph.D. Pres of Regenerative Medicine & Biologics Innovation
Mr. Scott M. Turner Sr. VP of Operations & Procurement
Mr. William L. Phelan Sr. VP & Chief Accounting Officer
Mr. Matthew M. Notarianni Head of Investor Relations
Mr. Mark P. Graves Sr. VP & Chief Compliance Officer
Hilary Dixon VP of Investor Relations & Corp. Strategic Communications

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 82.486
Price-to-Sales TTM: 1.2984
IPO Date: 2007-08-22
Fiscal Year End: December
Full Time Employees: 811
Back to stocks